Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-16 4:10 pm Purchase | 13G | HOOKIPA Pharma Inc. HOOK | Redmile Group LLC | 2,653,902 9.9% | 761,381 (+40.23%) | View |
| 2021-02-16 4:10 pm Purchase | 13G | Gritstone bio Inc. GRTS | Redmile Group LLC | 4,915,729 9.9% | 1,799,135 (+57.73%) | View |
| 2021-02-16 4:10 pm Purchase | 13G | Epizyme Inc. EPZM | Redmile Group LLC | 10,225,405 9.9% | 1,088,032 (+11.91%) | View |
| 2021-02-16 4:09 pm Purchase | 13G | ATARA BIOTHERAPEUTICS INC ATRA | Redmile Group LLC | 7,863,613 9.9% | 2,369,504 (+43.13%) | View |
| 2021-02-16 4:09 pm Purchase | 13G | Zentalis Pharmaceuticals Inc. ZNTL | Redmile Group LLC | 2,416,406 6% | 2,416,406 (New Position) | View |
| 2021-02-16 4:09 pm Purchase | 13G | KINETA INC. KA | Redmile Group LLC | 673,549 6.6% | 673,549 (New Position) | View |
| 2021-02-16 4:09 pm Sale | 13G | Wave Life Sciences Ltd. WVE | Redmile Group LLC | 79,018 0.2% | -3,247,475 (-97.62%) | View |
| 2021-02-16 4:09 pm Sale | 13G | UNIQURE N V QURE | Redmile Group LLC | 1,028,898 2.3% | -1,524,427 (-59.70%) | View |
| 2021-02-16 4:09 pm Purchase | 13G | TCR2 THERAPEUTICS INC. TCRR | Redmile Group LLC | 2,832,888 8.5% | 1,033,700 (+57.45%) | View |
| 2021-02-16 4:09 pm Purchase | 13G | Stoke Therapeutics Inc. STOK | Redmile Group LLC | 2,686,234 7.4% | 2,686,234 (New Position) | View |
| 2021-02-16 4:08 pm Purchase | 13G | STEREOTAXIS INC STXS | Redmile Group LLC | 7,833,765 9.9% | 780,303 (+11.06%) | View |
| 2021-02-16 4:08 pm Purchase | 13G | Scholar Rock Holding Corp SRRK | Redmile Group LLC | 3,412,009 9.9% | 471,120 (+16.02%) | View |
| 2021-02-16 4:08 pm Sale | 13G | REGENXBIO Inc. RGNX | Redmile Group LLC | 2,123,492 5.7% | -384,894 (-15.34%) | View |
| 2021-02-16 4:08 pm Sale | 13G | PLIANT THERAPEUTICS INC. PLRX | Redmile Group LLC | 3,388,376 9.6% | -22,281 (-0.65%) | View |
| 2021-02-16 4:08 pm Purchase | 13G | KRYSTAL BIOTECH INC KRYS | Redmile Group LLC | 1,675,036 8.5% | 584,836 (+53.64%) | View |
| 2021-02-16 4:07 pm Purchase | 13G | GenMark Diagnostics Inc. GNMK | Redmile Group LLC | 4,537,400 6.3% | 4,537,400 (New Position) | View |
| 2021-02-16 4:07 pm Sale | 13G | Deciphera Pharmaceuticals Inc. DCPH | Redmile Group LLC | 4,437,968 7.8% | -271,530 (-5.77%) | View |
| 2021-02-16 4:07 pm Purchase | 13G | CELLDEX THERAPEUTICS INC C CLDX | Redmile Group LLC | 2,711,616 6.9% | 2,711,616 (New Position) | View |
| 2021-02-16 4:07 pm Purchase | 13G | CABALETTA BIO INC CABA | Redmile Group LLC | 1,378,319 5.7% | 1,378,319 (New Position) | View |
| 2021-02-16 4:06 pm Purchase | 13G | Beam Therapeutics Inc. BEAM | Redmile Group LLC | 3,778,262 6.5% | 3,778,262 (New Position) | View |